Creo Medical Group Stock Fundamentals
| CREO Stock | 16.63 0.50 3.10% |
Creo Medical Group fundamentals help investors to digest information that contributes to Creo Medical's financial success or failures. It also enables traders to predict the movement of Creo Stock. The fundamental analysis module provides a way to measure Creo Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Creo Medical stock.
At this time, Creo Medical's Cost Of Revenue is comparatively stable compared to the past year. Interest Income is likely to gain to about 735 K in 2024, despite the fact that EBIT is likely to grow to (22.9 M). Creo | Select Account or Indicator |
Creo Medical Group Company Operating Margin Analysis
Creo Medical's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Creo Medical Operating Margin | (0.89) % |
Most of Creo Medical's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Creo Medical Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Creo Medical Group has an Operating Margin of -0.8947%. This is much lower than that of the Health Care Equipment & Supplies sector and significantly lower than that of the Health Care industry. The operating margin for all United Kingdom stocks is notably higher than that of the company.
Creo Medical Group Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Creo Medical's current stock value. Our valuation model uses many indicators to compare Creo Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Creo Medical competition to find correlations between indicators driving Creo Medical's intrinsic value. More Info.Creo Medical Group is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Creo Medical's earnings, one of the primary drivers of an investment's value.Creo Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Creo Medical's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Creo Medical could also be used in its relative valuation, which is a method of valuing Creo Medical by comparing valuation metrics of similar companies.Creo Medical is currently under evaluation in operating margin category among its peers.
Creo Fundamentals
| Return On Equity | -0.38 | ||||
| Return On Asset | -0.2 | ||||
| Profit Margin | (0.74) % | ||||
| Operating Margin | (0.89) % | ||||
| Current Valuation | 72.92 M | ||||
| Shares Outstanding | 412.15 M | ||||
| Shares Owned By Insiders | 20.44 % | ||||
| Shares Owned By Institutions | 48.82 % | ||||
| Price To Book | 1.45 X | ||||
| Price To Sales | 2.26 X | ||||
| Revenue | 30.8 M | ||||
| Gross Profit | 11.59 M | ||||
| EBITDA | (20.7 M) | ||||
| Net Income | (21.7 M) | ||||
| Total Debt | 8.3 M | ||||
| Book Value Per Share | 0.13 X | ||||
| Cash Flow From Operations | (21.6 M) | ||||
| Earnings Per Share | (0.06) X | ||||
| Target Price | 57.5 | ||||
| Number Of Employees | 278 | ||||
| Beta | 0.85 | ||||
| Market Capitalization | 68.52 M | ||||
| Total Asset | 76.6 M | ||||
| Retained Earnings | (130.8 M) | ||||
| Working Capital | 28 M | ||||
| Net Asset | 76.6 M |
About Creo Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Creo Medical Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Creo Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Creo Medical Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | -230 K | -241.5 K | |
| Total Revenue | 30.8 M | 32.3 M | |
| Cost Of Revenue | 15.5 M | 16.3 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Creo Stock Analysis
When running Creo Medical's price analysis, check to measure Creo Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Creo Medical is operating at the current time. Most of Creo Medical's value examination focuses on studying past and present price action to predict the probability of Creo Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Creo Medical's price. Additionally, you may evaluate how the addition of Creo Medical to your portfolios can decrease your overall portfolio volatility.